The history of Sildenafil presents a complex picture for shareholders. While the initial launch generated massive profits, the expiration of its patent opened the floodgates to off-brand versions, dramatically https://monobookmarks.com/story21532942/sildenafil-and-big-pharma-a-risky-investment